Beam Therapeutics Presents Updated Data from Novel Base Editing Programs for Sickle Cell Disease
BEAM-101 Data Highlight Precision of Base Editor with No Off-Target Editing Observed; Will Support Planned IND Submission in the Second...
top of page
A L T I T U D E
Life Science Ventures
Companies in the News
bottom of page